Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Research output
Activities
Press/Media
Prizes
Search by expertise, name or affiliation
Novel Molecular Therapeutics to Modulate Serotonin 5-HT2A Receptor Function
Cunningham, Kathryn
(PI)
Pharmacology & Toxicology
Center for Addiction Sciences and Therapeutics
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
4/1/21
→
3/11/22
Funding
VidaLibreBio, Inc:
$750,252.00
View all
View less